Overview

Study of Dual Trigger Ovulation in Oocyte Donors

Status:
Terminated

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

The project is a randomized, controlled, prospective study of oocyte donors comparing the safety and efficacy of triggering ovulation using a combination of two drugs-GnRH agonist and very low dose hCG-versus triggering ovulation with a standard hCG dose alone or a standard GnRH trigger alone.

Phase:

Phase 4

Details

Lead Sponsor:

Weill Medical College of Cornell University

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Leuprolide